Zymeworks (ZYME) Change in Taxes (2022 - 2026)
Zymeworks recorded quarterly Change in Taxes of -$16000.0 in Q1 2026, up 98.29% quarter-over-quarter from -$933000.0 in Q4 2025, and down 1500.0% year-over-year from $1142.9 in Q1 2025.
Zymeworks' Change in Taxes history runs 5 years deep, the most recent figure standing at -$16000.0 for Q1 2026.
- In Q1 2026, Change in Taxes fell 1500.0% year-over-year to -$16000.0; the TTM figure through Mar 2026 stood at -$60000.0 (up 96.54% YoY), while the FY2025 annual figure was -$45000.0, up 97.32% from the prior year.
- Change in Taxes came in at -$16000.0 for Q1 2026 at Zymeworks, up from -$933000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $979000.0 in Q4 2023 to a low of -$1.9 million in Q4 2024.
- A 5-year average of $5153.8 and a median of $50000.0 in 2024 frame the typical range for Change in Taxes.
- Across the five-year window, Change in Taxes surged 567.88% in 2025 and tumbled 1500.0% in 2026, its largest moves.
- Zymeworks' Change in Taxes stood at $840000.0 in 2022, then gained by 16.55% to $979000.0 in 2023, then slumped by 298.47% to -$1.9 million in 2024, then soared by 51.98% to -$933000.0 in 2025, then surged by 98.29% to -$16000.0 in 2026.
- According to Business Quant data, Change in Taxes over the past three periods registered -$16000.0, -$933000.0, and $915000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | -16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1.94 Mn |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 979,000.00 |
| Dec 31, 2023 | 979,000.00 |
| Sep 30, 2023 | -327,000.00 |
| Sep 30, 2023 | -327,000.00 |
| Jun 30, 2023 | 318,000.00 |
| Jun 30, 2023 | 318,000.00 |
| Dec 31, 2022 | 840,000.00 |
| Dec 31, 2022 | 840,000.00 |